Thus, the results of the present study provide further insights into the molecular mechanism by which the TME functions in cancer therapy through IL-6/JAK2/BECN1-induced autophagy and show that BECN1 Y333 phosphorylation levels may serve as a predictor of chemotherapy resistance and a poor outcome in cancers, including CRC. Here, BECN1 is linked to colorectal carcinoma.